🇺🇸 FDA
Patent

US 12226488

Nitroreductase-releasable pro-drugs and methods for using the same

granted A61KA61K47/549

Quick answer

US patent 12226488 (Nitroreductase-releasable pro-drugs and methods for using the same) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K47/549